Xiangrong Dai

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Ejection Fraction

Small Cell Lung Cancer

Peritoneal Dialysis

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jusheng An, Jie Tang, Benjamin X Li, Huihua Xiong, Hui Qiu, Lin Luo, Li Wang, Danbo Wang, Qi Zhou, Qin Xu, Honglin Song, Yunyan Zhang, Hong-Ping Zhang, Yujie Li, Xiaohui Yu, Jing Zhang, Rachel Ng, Wayne Zhao, Michael Wong, Xiangrong Dai, Guiling Li, Ling-Ying Wu
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Yan Zhou, Qing-Cheng Yang, Yang Dong, Tong Ji, Bing Zhang, Cheng Yang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Weibin Zhang, Yingqi Hua, Hongyu Bai, Jiayi Zhao, Benjamin X Li, Xiangrong Dai, Jianjun Zhang, Hai-Yan Hu, Yang Yao
First-in-maintenance therapy for localized high-grade osteosarcoma: an open-label phase I/II trial of the anti-PD-L1 antibody ZKAB001. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)